Alvotech/$ALVO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
Ticker
$ALVO
Sector
Trading on
Industry
Biotechnology
Headquarters
Luxembourg, Luxembourg
Employees
1,012
ISIN
LU2458332611
Website
Alvotech Metrics
BasicAdvanced
$3.4B
33.43
$0.34
-0.02
-
Price and volume
Market cap
$3.4B
Beta
-0.02
52-week high
$14.65
52-week low
$7.35
Average daily volume
200K
Financial strength
Current ratio
1.726
Quick ratio
1.006
Long term debt to equity
-391.392
Total debt to equity
-405.888
Interest coverage (TTM)
0.85%
Management effectiveness
Return on assets (TTM)
7.02%
Return on equity (TTM)
-20.09%
Valuation
Price to earnings (TTM)
33.426
Price to revenue (TTM)
5.334
Price to book
-10.54
Price to tangible book (TTM)
-9.51
Price to free cash flow (TTM)
-13.96
Growth
Revenue change (TTM)
413.92%
Earnings per share change (TTM)
-115.98%
3-year revenue growth (CAGR)
146.40%
3-year earnings per share growth (CAGR)
2.20%
Alvotech News
AllArticlesVideos
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
GlobeNewsWire·23 hours ago
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
GlobeNewsWire·23 hours ago
Alvotech Annual General Meeting to be held June 25, 2025
GlobeNewsWire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alvotech stock?
Alvotech (ALVO) has a market cap of $3.4B as of May 29, 2025.
What is the P/E ratio for Alvotech stock?
The price to earnings (P/E) ratio for Alvotech (ALVO) stock is 33.43 as of May 29, 2025.
Does Alvotech stock pay dividends?
No, Alvotech (ALVO) stock does not pay dividends to its shareholders as of May 29, 2025.
When is the next Alvotech dividend payment date?
Alvotech (ALVO) stock does not pay dividends to its shareholders.
What is the beta indicator for Alvotech?
Alvotech (ALVO) has a beta rating of -0.02. This means that it has an inverse relation to market volatility.